BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 24.23 | 13.09 | -1,872.75 | 11.32 | 7.30 |
What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 24.23 |
| Mar2025 | 13.09 |
| Mar2024 | -1,872.75 |
| Mar2023 | 11.32 |
| Mar2022 | 7.30 |
How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 24.23 | 85.10 | |
| Mar2025 | 13.09 | Positive | |
| Mar2024 | -1872.75 | Negative | |
| Mar2023 | 11.32 | 55.07 | |
| Mar2022 | 7.3 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹109.0 Cr | -2.8% | -16.8% | -54.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹353,335.0 Cr | 2.6% | -13.1% | 7.4% | Stock Analytics | |
| ADITYA INFOTECH | ₹47,149.5 Cr | -1.5% | -0.1% | 184.7% | Stock Analytics | |
| PREMIER ENERGIES | ₹40,333.6 Cr | 3% | -0.9% | -19.4% | Stock Analytics | |
| AEGIS LOGISTICS | ₹38,645.1 Cr | -15% | -15.7% | 50.9% | Stock Analytics | |
| REDINGTON | ₹25,810.3 Cr | -10.9% | -19.4% | 35.2% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.8% |
-16.8% |
-54.1% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses